SAMUEL D COLELLA
CIK 1201580 · last filed 2021-11-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$186.46M
Companies
11
Total Filings
110
Lifetime Open-Market Net
$103.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FLXN | Director | 0 | $25.05 | $0 | $115.22M | 21 | 2021-11-19 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 230,381 | $3.71 | $854.7K | -$2.05M | 35 | 2020-03-12 |
| GKOS | 10%+ Owner | 397 | $126.81 | $50.3K | -$8.17M | 2 | 2016-06-02 |
| INGN | 10%+ Owner | 58,495 | $6.40 | $374.4K | -$1.62M | 2 | 2015-05-11 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 41,742 | — | — | -$4.64M | 27 | 2014-10-03 |
| VCYT | Director | 3,594,989 | $47.33 | $170.15M | $0 | 1 | 2013-11-04 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 4,730 | — | — | $0 | 8 | 2012-09-07 |
| JAZZ | Director | 44,024 | $230.56 | $10.15M | $0 | 10 | 2012-01-13 |
| HELICOS BIOSCIENCES CORP (HLCS) Delisted | 10%+ Owner | 10,709,818 | — | — | $4.88M | 2 | 2009-09-21 |
| SYMYX TECHNOLOGIES INC (SMMX) Delisted | Director | 11,938 | — | — | $0 | 1 | 2007-06-14 |
| PODD | 38,301 | $149.70 | $5.73M | $0 | 1 | 2007-05-17 |
Recent Filings · Page 8 of 11
110 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-05-18 | GENOMIC HEALTH INC (GHDX) Delisted | Mixed | −522,292 | -$868.5K | EDGAR |
| 2012-05-18 | STANDARD BIOTOOLS INC. (FLDM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-04-03 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +326 | $10.0K | EDGAR |
| 2012-01-13 | JAZZ | Mixed | +38,347 | $114 | EDGAR |
| 2012-01-06 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +393 | $10.0K | EDGAR |
| 2011-11-08 | JAZZ | Grant (A) | — | $0 | EDGAR |
| 2011-10-04 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +454 | $10.0K | EDGAR |
| 2011-09-09 | STANDARD BIOTOOLS INC. (FLDM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-08-01 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-07-06 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +358 | $10.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.